ABSTRACT
BACKGROUND: In the cetuximab after progression in KRAS wild-type colorectal cancer patients (CAPRI) trial patients with metastatic colorectal cancer (mCRC) received 5-fluorouracil, folinic acid and irinotecan (FOLFIRI) and cetuximab in first line followed by 5-Fluorouracil, folinic acid, oxaliplatin (FOLFOX) with or without cetuximab until progression. Limited data are available on the efficacy and safety of anti-epidermal growth factor receptor (anti-EGFR) agents on elderly patients with mCRC. In the current study we evaluated the efficacy and safety of FOLFIRI plus cetuximab in age-defined subgroups. METHODS: A post-hoc analysis was performed in CAPRI trial patients; outcomes (progression-free survival (PFS), overall response rate (ORR), safety) were analysed by age-groups and stratified according to molecular characterisation. 3 age cut-offs were used to define the elderly population (≥65; ≥70 and ≥75â years). RESULTS: 340 patients with mCRC were treated in first line with FOLFIRI plus cetuximab. Among those, 154 patients were >65â years, 86 >70â years and 35 >75â years. Next-generation sequencing (NGS) was performed in 182 patients. Among them, 87 patients were >65â years, 46 >70 and 17 >75. 104 of 182 patients were wild type (WT) for KRAS, NRAS, BRAF, PIK3CA genes. In the quadruple WT group, 51 patients were ≥65â years; 29 were ≥70; 9 were ≥75. Median PFS was similar within the age-subgroups in the intention-to-treat population, NGS cohort and quadruple WT patients, respectively. Likewise, ORR was not significantly different among age-subgroups in the 3 populations. Safety profile was acceptable and similarly reported among all age-groups, with the exception of grade ≥3 diarrhoea (55% vs 25%, p=0.04) and neutropaenia (75% vs 37%, p=0.03) in patients ≥75â years and grade ≥3 fatigue (31% vs 20%, p=0.01) in patients <75â years. CONCLUSIONS: Tolerability of cetuximab plus FOLFIRI was acceptable in elderly patients. Similar ORR and PFS were observed according to age-groups. No differences in adverse events were reported among the defined subgroups with the exception of higher incidence of grade ≥3 diarrhoea and neutropaenia in patients ≥75â years and grade ≥3 fatigue in patients <75â years. TRIAL REGISTRATION NUMBER: 2009-014041-81.
ABSTRACT
The present study assesses the accuracy with which the subject specific coordinates of the hip joint centre (HJC) in a pelvic anatomical frame can be estimated using different methods. The functional method was applied by calculating the centre of the best sphere described by the trajectory of markers placed on the thigh during several trials of hip rotations. Different prediction methods, proposed in the literature and in the present investigation, which estimate the HJC of adult subjects using regression equations and anthropometric measurements, were also assessed. The accuracy of each of the above-mentioned methods was investigated by comparing their predictions with measurements obtained on a sample of 11 male adult able-bodied volunteers using roentgen stereophotogrammetric analysis (RSA), assumed to provide the true HJC locations. Prediction methods estimated the HJC location at an average rms distance of 25-30 mm. The functional method performed significantly better and estimated HJCs within a rms distance of 13 mm on average. This result may be confidently generalised if the photogrammetric experiment is carefully conducted and an optimal analytical approach used. The method is therefore suggested for use in motion analysis when the subject's hip range of motion is not limited. In addition, the facts that it is not an invasive technique and that it has relatively small and un-biased errors, make it suitable for regression equations identification with no limit to sample size and population typology.
Subject(s)
Hip Joint/diagnostic imaging , Photogrammetry , Adult , Anthropometry/methods , Biomechanical Phenomena , Evaluation Studies as Topic , Forecasting , Hip Joint/anatomy & histology , Hip Joint/physiology , Humans , Male , Models, Anatomic , Radiography , Regression Analysis , Rotation , Thigh/physiologyABSTRACT
Cytogenetic investigations and molecular analysis of the Y chromosome by the polymerase chain reaction amplification of sequence-tagged sites (STS-PCR) technique were performed in 126 patients affected by idiopathic oligo-azoospermia following accurate selection of cases. Seventeen patients evidenced an abnormal karyotype. Fourteen patients with a normal karyotype had microdeletions of the Y chromosome within interval 6. In azoospermic patients microdeletions were scattered along different subintervals, while in oligozoospermic patients they were clustered in subinterval 6E. The size of the deletion was not apparently related to the severity of the disease. These results suggest that cytogenetic analysis and the STS-PCR technique can detect a genetic cause of infertility in about one-quarter of patients with idiopathic oligo-azoospermia.
Subject(s)
Chromosome Aberrations , Oligospermia/genetics , Y Chromosome , Adult , Chromosome Deletion , Humans , In Situ Hybridization, Fluorescence , In Vitro Techniques , Karyotyping , Male , Middle Aged , Oligospermia/pathology , Testis/pathologyABSTRACT
Y chromosome molecular analysis was performed using the STS-PCR technique in 50 patients with oligozoospermia. Microdeletions of interval 6 of the Y chromosome were detected in seven patients, in six of whom subinterval E was affected. All patients retained the RBM1 and DAZ genes, while in one deletion involved the SPGY gene. The size of the deletion was not apparently related to the severity of the disease. These results suggest the presence of an oligozoospermia critical region on the Y chromosome within subinterval E of interval 6.
Subject(s)
Chromosome Deletion , Oligospermia/genetics , RNA-Binding Proteins/genetics , Y Chromosome , Adult , Deleted in Azoospermia 1 Protein , Humans , Male , Middle Aged , Multigene Family , Polymerase Chain ReactionABSTRACT
Nowadays, quality has become a very important factor in almost all areas of endeavour. The data generated from tests for the assessment of potentially toxic chemicals is obviously no exception. It is necessary, therefore, that quality systems be developed to ensure that the data generated to support these tests are of good quality. An acceptable quality system should require that, where applicable, the tests be performed according to defined guidelines. Once defined guidelines have been identified for the type of test to be performed, it is then necessary to design a plan which describes how, when, where and by whom the data will be generated. If at all possible, the data should be generated according to written standard procedures which provide for the production of data to the same quality standard. The data should be generated and collected by properly trained staff using data collection systems (paper or electronic media) which ensure the accuracy, reliability and integrity of the data recorded. The data must then be recorded in such a way as to ensure that they are reported completely clearly and accurately. The report, whether it be in the form of scientific article, monograph or formal study report, should present the data in a consistent manner and allow for adequate reconstruction of the events which took place during the test. Finally, the report and the data supporting it should be verified to ensure that the test was carried out according to the relevant guidelines (if used), that the study plan was correctly followed and finally that all data were properly generated and accurately reported in the report.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Databases, Factual , Toxicology/standards , Laboratories/standards , Quality ControlABSTRACT
A case with histological evidence of malignancy developed in a branchial cleft cyst (BCC), which conforms with the criteria for primary branchiogenic carcinoma (PBC) was analyzed by electron microscopy and immunchistochemistry; our findings reveal peculiar analogies between PBC and BBC, further supporting the primitive nature of the lesion.
ABSTRACT
A case of single pulmonary leiomyoma with giant cyst formation is presented. Metastasizing uterine fibroleiomyoma and fibroleiomyomatous hamartoma both give rise to multiple pulmonary nodules on chest films. Leiomyoma of the lung presenting as a single pedunculated lesion with cyst formation is exceptional. This report documents the existence of other rare cystic lesions that may mimic the more common cystic air space and bullous disease.
Subject(s)
Cysts/diagnosis , Leiomyoma/diagnosis , Lung Diseases/diagnosis , Lung Neoplasms/diagnosis , Cysts/surgery , Diagnosis, Differential , Female , Humans , Leiomyoma/surgery , Lung Diseases/surgery , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Middle Aged , Thoracotomy , Uterine Neoplasms/pathologyABSTRACT
The difficult differential diagnosis between the diffuse variants of cutaneous lymphoid hyperplasia (CLH; synonym; pseudolymphoma) and malignant follicular center cell lymphomas (FCCL) often requires a multidisciplinary approach. Eighteen CLH and 11 FCCL, diagnosed by conventional histology and immunophenotyping and subsequently examined with a polymerase chain reaction to show clonal immunoglobulin heavy-chain gene rearrangements, were subjected to a novel type of automated nuclear image analysis. Of all nuclear parameters tested in azure A-stained semithin sections, the mean nuclear profile area (TN) of lymphoid cells was the best criterion to distinguish between CLH and FCCL (p = 9 x 10(-6)). Additional distinctive features, in the order of decreasing significance, were the SD of TN; all chromatin textural parameters combined; and the light and the dark fractions of the central nuclear profile areas. Parameters related to the chromatin pattern were independent of nuclear profile size in FCCL, but not in CLH. Two lesions registered as CLH displayed the nuclear characteristics favoring this diagnosis, but showed B-cell monoclonality at the DNA level. In conclusion, computerized nuclear image analysis is a helpful additional diagnostic tool in the evaluation of diffuse CLH and cutaneous FCCL.
Subject(s)
Cell Nucleus/ultrastructure , Image Processing, Computer-Assisted , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Lymphoma, Follicular/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Skin Neoplasms/pathology , Adolescent , Adult , Aged , Aged, 80 and over , B-Lymphocytes/pathology , B-Lymphocytes/ultrastructure , Child , Child, Preschool , Chromatin/ultrastructure , DNA/analysis , Diagnosis, Differential , Female , Humans , Immunophenotyping , Leukemia, Lymphocytic, Chronic, B-Cell/ultrastructure , Lymphoma, Follicular/ultrastructure , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Male , Middle Aged , Polymerase Chain Reaction , Skin Neoplasms/ultrastructureABSTRACT
Diffuse subtypes of cutaneous lymphoid hyperplasia (CLH; n = 18) and primary malignant follicular center cell lymphoma of the skin (FCCL, n = 11) were diagnosed by conventional histology, immunophenotyping on paraffin sections, and gene rearrangement analysis. We then counted on semithin, Azur A-stained sections of resin-re-embedded biopsy specimens the relative numbers of apoptotic bodies among all lymphoid cells (apoptotic index [AI]). The diagnostic value of AI was compared to that of mitotic indices (MI) and percentages of various cell types in the cutaneous infiltrate. Features of cellular infiltrates distinguishing to two groups of lesions, in the order of decreasing significance, were percent large lymphoid cells, percent medium-sized lymphoid cells (both higher in FCCL); percent small lymphoid cells, percent epithelioid/giant cells, and percent histiocytes/macrophages (all three higher in CLH). However, of all parameters tested, AI had the greatest discriminant value (median in FCCL 1.11%, in CLH 0.14%; p = 8 x 10(-6)). Two cases, diagnosed as CLH with all morphologic and immunologic methods used, showed B-cell monoclonality at the DNA level. Linear discriminant analysis determined the following order of distinctive power of variables: 1) AI; 2) MI; 3) percent small lymphoid cells; 4) percent medium-sized lymphoid cells; 5) percent large lymphoid cells; 6) percent epithelioid/giant cells; and 7) percent histiocytes/macrophages. The present study thus establishes AI as an important parameter in the differentiation of diffuse CLH from diffuse cutaneous FCCL.
Subject(s)
Apoptosis , Lymphoid Tissue/pathology , Lymphoma, Follicular/pathology , Skin Neoplasms/pathology , Skin/pathology , Adult , Aged , Aged, 80 and over , Child, Preschool , Diagnosis, Differential , Female , Gene Rearrangement , Humans , Hyperplasia , Immunoglobulin Heavy Chains/genetics , Immunophenotyping , Male , Middle Aged , Mitotic Index , Polymerase Chain ReactionABSTRACT
The aim of this study was to try to place gastric intestinal metaplasia, type III (type III IM) in the stepwise chain of events from atrophic gastritis to cancer. A number of dysplastic, periulcer regenerative, and type III IM lesions were qualitatively diagnosed (and graded) blindly and independently by several pathologists. These lesions were further analysed by means of quantitative parameters, with the aim of differentiating dysplastic from regenerative changes. Inconsistencies between the qualitative and quantitative classification (about 7 per cent of cases) were eliminated and homogeneous groups (low-grade dysplasia, high-grade dysplasia, regenerative changes) were obtained. These cases were taken as the gold standard against which type III IM was compared. The results indicate that the great majority (91.4 per cent) of cases of type III IM fulfil the nuclear and architectural criteria for low-grade dysplasia.
Subject(s)
Stomach/pathology , Adult , Aged , Aged, 80 and over , Female , Gastric Mucosa/pathology , Humans , Male , Metaplasia , Middle Aged , Stomach Ulcer/pathologyABSTRACT
Our investigation did not confirm the general experience that significant numbers of cases initially considered malignant mesothelioma or metastatic carcinoma are actually found to be metastatic carcinoma or malignant mesothelioma, respectively, upon deeper investigation using ancillary techniques (e.g., histochemistry, immunohistochemistry, electron microscopy). Well-trained pathologists, expert in thoraco-pulmonary pathology, have a high inter- and intra-rater agreement and significantly better results than standard hospital pathologists in correctly differentiating malignant mesothelioma from metastatic carcinoma. Therefore, epidemiologic investigations which exclude an accurate and rigorous reevaluation of the histologic slides have to be considered unreliable, unless the data come from a specialized medical center experienced in this type of pathology.
Subject(s)
Mesothelioma/pathology , Pleural Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Female , Humans , Italy , Male , Middle AgedABSTRACT
Macroscopic and microscopic features of tumours have been analysed in 37 bronchiolo-alveolar carcinomas. Lymphocytes, Langerhans cells, collagen (mature and/or myofibroblastic), were quantitatively or semiquantitatively evaluated. Histology, stage, type of fibrosis, nuclear profile features (area and shape factors), amount and type of mucin secreted, number of mitoses, Langerhans cells, myofibroblasts and LeuM1+ cells were not related to survival. Gross morphology of the tumour and, to a lesser extent, lymphoid infiltrates (in particular UCHL1+ and L26+ peritumoral lymphoid cells) were the only variables significantly related to survival. Estimated survival functions were computed according to Cox's model: well demarcated tumours behaved significantly better than poorly demarcated tumours and even more so than diffuse or multiple mass. Lymphoid infiltrates were significantly more represented in and around well demarcated tumours: however, their survival predicting value was less than that of the gross type.
Subject(s)
Adenocarcinoma, Bronchiolo-Alveolar/mortality , Adenocarcinoma, Bronchiolo-Alveolar/pathology , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Adenocarcinoma, Bronchiolo-Alveolar/chemistry , Adult , Aged , Cell Nucleus/pathology , Collagen/analysis , Female , Humans , Immunohistochemistry , Langerhans Cells/pathology , Lung Neoplasms/chemistry , Lymphocytes/pathology , Male , Middle Aged , PrognosisABSTRACT
The differential diagnosis based on morphology between neuroblastoma (NB) and peripheral neuroepithelioma (PN) is difficult, since these tumors share many architectural and cytological features. In this study, a morphometrical approach to this diagnosis is made by using nuclear (shape factors) and tissue (volume density of nuclei and stroma) parameters. Quantitative morphological analysis adds important information, which when used with clinical and biochemical data facilitates the distinction. In the majority of cases, nuclei of PN are significantly less round than those of NB and their profile is much more irregular. The density of neoplastic nuclei is significantly higher in PN. However, in a certain number of cases, even the morphometrical study confirms how difficult it may be to differentiate these two neoplastic entities, since the values of parameters are largely overlapping. This suggests the existence of a "continuum" of changing features between NB and PN, which may substantiate the hypothesis of a common histogenesis.
Subject(s)
Adrenal Gland Neoplasms/diagnosis , Mediastinal Neoplasms/diagnosis , Neuroblastoma/diagnosis , Neuroectodermal Tumors, Primitive, Peripheral/diagnosis , Thoracic Neoplasms/diagnosis , Adolescent , Adrenal Gland Neoplasms/pathology , Adrenal Gland Neoplasms/ultrastructure , Adult , Cell Nucleus/ultrastructure , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Infant , Male , Mediastinal Neoplasms/pathology , Mediastinal Neoplasms/ultrastructure , Middle Aged , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Neuroectodermal Tumors, Primitive, Peripheral/pathology , Neuroectodermal Tumors, Primitive, Peripheral/ultrastructure , Thoracic Neoplasms/pathology , Thoracic Neoplasms/ultrastructureABSTRACT
Dopamine (DA) and serotonin (5-HT) are the neurotransmitters most directly involved in sexual activity. DA plays a stimulatory role while 5-HT has an inhibitory effect. The two monoaminergic systems modulate the secretion of many hormones (GnRH, LH, testosterone, prolactin and endorphins) involved in sexual functional capacity. Furthermore, hormones influence synthesis and storage of brain neurotransmitters. Impotence can often be associated to clinical depression and altered neurotransmitter function. Moreover, stress represents an unbalance between various neurotransmitter systems and can induce impotence especially when disorders of the endorphinic system are present. Replacement therapy is based upon the understanding of these basic concepts. Impotence due to an underlying depressive illness must be treated with dopaminergic antidepressant drugs; while in stressful conditions a good response to the naloxone test is the preliminary criterion to subsequent naltrexone treatment. When a hormonal deficiency has been proved, the hormone replacement therapy is of course highly effective (gonadotropins in hypogonadotropic syndromes, testosterone in aging, etc.). Finally, idiopathic impotence could be treated by DA agonist and/or 5-HT antagonist drugs either alone or better yet in association with psychotherapy.
Subject(s)
Androgens/physiology , Endorphins/physiology , Neurotransmitter Agents/physiology , Sexual Dysfunction, Physiological/drug therapy , Adult , Animals , Dopamine/physiology , Endocrine Glands/physiology , Endocrine Glands/physiopathology , Humans , Male , Middle Aged , Nervous System/physiopathology , Nervous System Physiological Phenomena , Serotonin/physiology , Sexual Dysfunction, Physiological/physiopathologyABSTRACT
The prolactin (PRL) response to 20 mg of domperidone, a peripheral dopamine (DA) blocking agent, was evaluated in a group of 16 drug-free, acute, young schizophreniform and schizophrenic males and in a group of age-matched normal males. Although basal plasma PRL levels were normal, the PRL responses following domperidone were blunted in both patient groups. The PRL response was more blunted in the schizophreniform patients than in the schizophrenic patients. Possible explanations for these results include pharmacokinetic factors or abnormalities of the pituitary D2 DA receptors.
Subject(s)
Domperidone , Military Personnel/psychology , Prolactin/blood , Psychotic Disorders/diagnosis , Schizophrenia/diagnosis , Schizophrenic Psychology , Acute Disease , Adult , Brain/drug effects , Humans , Male , Psychotic Disorders/blood , Psychotic Disorders/psychology , Receptors, Dopamine/drug effects , Receptors, Dopamine D1 , Receptors, Dopamine D2 , Schizophrenia/bloodABSTRACT
Type I and type III intestinal metaplasia in gastric mucosa have been examined using morphometric methods. Tissue (volume per cent gland, lumen, epithelium, goblet cell vacuoles) and nuclear parameters (area, with related standard deviation, and form factors) were used as indicators of gland crowding, nuclear-cytoplasmic ratio, nuclear atypia, and pleomorphism. In type III intestinal metaplasia, there is significantly (i) greater nuclear pleomorphism, (ii) a higher nuclear-cytoplasmic ratio, and (iii) smaller and less numerous goblet cell vacuoles in both the upper and the lower parts of the crypts. These two parameters have significantly higher values in the lower than in the upper part of individual crypts. No cell population with large pleomorphic nuclei characterized type III metaplasia, though there was more variation in nuclear size.
Subject(s)
Stomach/pathology , Adult , Aged , Aged, 80 and over , Cell Nucleus/ultrastructure , Epithelium/pathology , Exocrine Glands/pathology , Female , Gastric Mucosa/pathology , Humans , Male , Metaplasia/pathology , Middle Aged , Mucins/analysis , Mucus/analysis , Sialomucins , Vacuoles/ultrastructureABSTRACT
We report an unusual case of primary intrathoracic extrapulmonary hemangiopericytoma. Despite the large size and rapid growth of the tumor, no histological sign of malignancy was present. Tumor cells immunostained positively only to vimentin.